NASDAQ:BLRX - BIOLINERX LTD/S SEC Filings & 10K Form

$0.35
+0.01 (+2.94 %)
(As of 06/20/2019 08:00 AM ET)
Today's Range
$0.34
Now: $0.35
$0.37
50-Day Range
$0.31
MA: $0.36
$0.41
52-Week Range
$0.31
Now: $0.35
$1.84
Volume682,200 shs
Average Volume535,996 shs
Market Capitalization$39.24 million
P/E RatioN/A
Dividend YieldN/A
Beta1.58

SEC Filings

BIOLINERX LTD/S (NASDAQ:BLRX) SEC Filings

DateFilerForm TypeView
06/05/2019
6:00 AM
BIOLINERX LTD/S (Filer)
Form 20-F/A
View Filing
05/28/2019
6:04 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/20/2019
11:26 AM
BIOLINERX LTD/S (Filer)
Form CT ORDER
View Filing
05/14/2019
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/07/2019
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/28/2019
6:08 AM
BIOLINERX LTD/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
View Filing
03/28/2019
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/27/2019
6:01 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/21/2019
12:14 PM
BIOLINERX LTD/S (Filer)
Form CT ORDER
View Filing
03/01/2019
4:12 PM
BIOLINERX LTD/S (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13D/A
View Filing
02/13/2019
11:15 PM
BIOLINERX LTD/S (Filer)
Form EFFECT
View Filing
02/08/2019
3:46 PM
BIOLINERX LTD/S (Subject)
Senvest Management, LLC (Filed by)
Form SC 13G
View Filing
02/08/2019
3:15 PM
BIOLINERX LTD/S (Subject)
Senvest Management, LLC (Filed by)
Form SC 13G/A
View Filing
02/07/2019
11:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/05/2019
4:12 PM
BIOLINERX LTD/S (Filer)
Form 424B5
View Filing
02/05/2019
8:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/04/2019
4:52 PM
BIOLINERX LTD/S (Filer)
Form 424B5
View Filing
02/04/2019
3:30 PM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/04/2019
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/26/2018
3:11 PM
BIOLINERX LTD/S (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
View Filing
12/11/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/04/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/20/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/08/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/22/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/19/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/18/2018
1:56 PM
BIOLINERX LTD/S (Filer)
Form CT ORDER
View Filing
10/11/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/03/2018
5:03 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/13/2018
6:01 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/07/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/01/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/30/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/18/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/22/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/17/2018
8:12 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/17/2018
7:57 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/16/2018
5:58 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/24/2018
6:01 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/16/2018
8:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/02/2018
12:19 PM
BIOLINERX LTD/S (Filer)
Form CT ORDER
View Filing
03/26/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/12/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/06/2018
6:06 AM
BIOLINERX LTD/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
View Filing
03/06/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/27/2018
6:30 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/12/2018
4:00 PM
BIOLINERX LTD/S (Subject)
Senvest Management, LLC (Filed by)
Form SC 13G/A
View Filing
01/23/2018
7:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/23/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/21/2018
11:15 PM
BIOLINERX LTD/S (Filer)
Form EFFECT
View Filing
01/19/2018
3:46 PM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/19/2018
3:45 PM
BIOLINERX LTD/S (Filer)
Form 424B5
View Filing
01/19/2018
6:01 AM
BIOLINERX LTD/S (Filer)
Form F-3/A
View Filing
01/17/2018
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/28/2017
3:33 PM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/28/2017
3:33 PM
BIOLINERX LTD/S (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
View Filing
12/21/2017
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/14/2017
5:03 AM
BIOLINERX LTD/S (Subject)
NOVARTIS PHARMA AG (Filed by)
Form SC 13G/A
View Filing
12/05/2017
7:47 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/04/2017
8:55 AM
BIOLINERX LTD/S (Filer)
Form CT ORDER
View Filing
12/04/2017
6:00 AM
BIOLINERX LTD/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
This page was last updated on 6/20/2019 by MarketBeat.com Staff

Featured Article: Cost of Equity

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel